Abstract
Early detection of colorectal cancer (CRC) through screening is the most effective method to reduce morbidity as well as mortality from this disease. Fecal immunochemical test (FIT)-based screening has shown to be effective, especially in multi-round population-based screening. However, its sensitivity and specificity are suboptimal, leaving room for improvement. In this perspective, the development journey of a new screening test, the multitargetFIT (mtFIT), which outperforms FIT, is described from discovery down to large-scale clinical utility testing and health technology assessment.
| Original language | English |
|---|---|
| Pages (from-to) | 1683-1693 |
| Number of pages | 11 |
| Journal | Digestive diseases and sciences |
| Volume | 70 |
| Issue number | 5 |
| Early online date | 2025 |
| DOIs | |
| Publication status | Published - May 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Biomarker development
- CRC screening
- Fecal immunochemical test (FIT)
- Multitarget fecal immunochemical test (mtFIT)
Fingerprint
Dive into the research topics of 'Developing a New Stool Test for Colorectal Cancer Screening, the multitargetFIT (mtFIT)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver